An IL-4/IL-13 dual antagonist reduces lung inflammation, airway hyperresponsiveness, and IgE production in mice. - Kasaian MT; Marquette K; Fish S; DeClercq C; Agostinelli R; Cook TA; Brennan A; Lee J; Fitz L; Brooks J; Vugmeyster Y; Williams CM; et al. (American journal of respiratory cell and molecular biology, 2013)